King Wealth Management Group’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,900
Closed -$212K 138
2019
Q1
$212K Sell
2,900
-1,000
-26% -$69K 0.07% 127
2018
Q4
$249K Buy
+3,900
New +$290K 0.09% 106

Other funds holding ANAB

King Wealth Management Group's ANAB Position: Q2 2019 in Review

King Wealth Management Group sold out of AnaptysBio (ANAB) in Q2 2019, closing a stake of 2,900 shares — an estimated $212K sold.

King Wealth Management Group first reported a position in ANAB in Q4 2018 and held it in 2 quarters. The position peaked at $249K in Q4 2018. 127 funds tracked by Wall St. Rank hold ANAB as of Q2 2019.

  • King Wealth Management Group reported no remaining AnaptysBio position as of Q2 2019 after selling out during the quarter.
  • King Wealth Management Group sold 2,900 AnaptysBio shares in Q2 2019, an estimated $212K.
  • King Wealth Management Group first reported a position in AnaptysBio in Q4 2018 and held it in 2 quarters.
  • King Wealth Management Group's AnaptysBio position peaked at $249K in Q4 2018.
  • 127 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2019.

Based on King Wealth Management Group's 13F filing for Q2 2019, filed 13 Aug 2019.